학술논문

Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children.
Document Type
Article
Source
Bone Marrow Transplantation. Mar2015, Vol. 50 Issue 3, p414-419. 6p.
Subject
*CELLULAR pathology
*CANCER treatment
*HEMATOPOIETIC stem cell transplantation
*TRANSPLANTATION of organs, tissues, etc.
HYPERPLASIA treatment
Language
ISSN
0268-3369
Abstract
Hepatic focal nodular hyperplasia (FNH) is a nonmalignant condition rarely affecting children previously treated for cancer, especially those who received hematopoietic SCT (HSCT). Some aspects of its pathogenesis still remain unclear and a strong association with specific risk factors has not yet been identified. We report here a single institution's case series of 17 patients who underwent HSCT and were diagnosed with FNH, analyzing retrospectively their clinical features and the radiological appearance of their hepatic lesions. We aimed to compare the diagnostic accuracy of ultrasound (US) and magnetic resonance imaging (MRI) and to explore the role of transient elastography (FibroScan) to evaluate the degree of hepatic fibrosis in FNH patients. Our analysis showed an association of FNH with age at transplant ⩽12 years (hazard ratio (HR) 9.10); chronic GVHD (HR 2.99); hormone-replacement therapy (HR 4.02) and abdominal radiotherapy (HR 4.37). MRI proved to be a more accurate diagnostic tool compared with US. Nine out of 12 patients who underwent FibroScan showed hepatic fibrosis. Our study points out that FNH is an emerging complication of HSCT, which requires a lifelong surveillance to follow its course in cancer patients. [ABSTRACT FROM AUTHOR]